enprofylline has been researched along with Airway Hyper-Responsiveness in 2 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erjefält, I | 1 |
| Persson, CG | 1 |
| Napier, FE | 1 |
| Temple, DM | 1 |
2 other studies available for enprofylline and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI.
Topics: Administration, Cutaneous; Administration, Topical; Animals; Budesonide; Guinea Pigs; Inflammation; | 1992 |
Theophylline's inhibition of antigen-induced contraction of human parenchymal strips is independent of adenosine antagonism.
Topics: Adenosine; Airway Resistance; Antigens; Bronchodilator Agents; Histamine Release; Humans; In Vitro T | 1987 |